• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Jay Bhattacharya, prominent physician and economist, nominated by Trump for NIH director

by November 27, 2024
written by November 27, 2024

Stanford-trained physician and economist Jay Bhattacharya has officially been nominated by President-elect Donald Trump to serve as the next director of the National Institutes of Health (NIH).

Trump made the announcement in a Truth Social post, writing: ‘I am thrilled to nominate Jay Bhattacharya, MD, PhD, to serve as Director of the National Institutes of Health. Dr. Bhattacharya will work in cooperation with Robert F. Kennedy Jr. to direct the Nation’s Medical Research, and to make important discoveries that will improve Health, and save lives.’

Bhattacharya met this week with Robert F. Kennedy Jr., who was nominated by Trump to lead the Department of Health and Human Services, which oversees the NIH and other health agencies, and impressed the former presidential candidate with his ideas to overhaul the NIH, which oversees U.S. biomedical research, according to a report by The Washington Post.

The NIH also awards funding grants to hundreds of thousands of researchers, oversees clinical trials on its Maryland campus and supports a variety of efforts to develop drugs and therapeutics.

The nominee for the NIH director must be confirmed by the Senate, which will have a Republican majority beginning in January.

Bhattacharya has called for moving the NIH’s focus toward funding more innovative research and cutting the influence of some of its longest-serving officials.

Kennedy Jr. has played a central role in choosing top health care staff and deputies for Trump’s next administration, including Johns Hopkins surgeon Marty Makary, who Trump selected to lead the Food and Drug Administration, and internal medicine physician and former Republican congressman from Florida Dave Weldon, who Trump chose to head the Centers for Disease Control and Prevention, according to the report.

Bhattacharya and Makary worked together on a blueprint for a proposed commission to investigate the nation’s coronavirus response, the report noted.

Trump’s selections of Makary, Weldon and family and emergency medicine physician Janette Nesheiwat, who the president-elect nominated to serve as surgeon general, also must be confirmed by the Senate.

Bhattacharya was a prominent critic of the federal government’s COVID-19 response during the early days of the pandemic. He co-wrote an open letter in October 2020, during Trump’s first term, that called for the government to roll back pandemic shutdowns but maintain ‘focused protections’ for vulnerable populations, such as the elderly.

The suggestion was supported by Republican lawmakers and many Americans who were critical of shutdowns and wanted to return to pre-pandemic life. However, public health experts, including then-NIH Director Francis S. Collins, criticized the proposal as premature and dangerous amid the spread of COVID-19 at a time when vaccines were not yet available.

Bhattacharya has also called for rolling back the power of some of the 27 institutes and centers that make up the NIH, arguing that some career civil servants wrongly shaped national policies at the height of the pandemic and did not allow dissenting perspectives.

He, along with other critics of the agency, have criticized former Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci, who helped shape the nation’s coronavirus response during the Trump and Biden administrations before leaving the federal government in December 2022.

The NIH has also been investigated by congressional lawmakers over the pandemic response, with Republicans charging that the agency’s leaders mismanaged the response to the virus and calling for the agency to be overhauled.

Current and former NIH officials, including Fauci, have defended the agency’s response, arguing that federal leaders generally did the best that they could to address the virus.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump team signs memorandum of understanding with Biden White House to formalize transition
next post
Legal challenges on administrative reach expected in Trump’s deregulatory scheme, experts say

related articles

Recess on ice as Republicans hunker down for...

August 1, 2025

Trump moves nuclear submarines weeks after praising sub’s...

August 1, 2025

WATCH: Trump says he is hopeful Hillary Clinton...

August 1, 2025

Iran says it has ‘plenty of scientists’ left...

August 1, 2025

Trump endorses ‘MAGA warrior’ for RNC chairman after...

August 1, 2025

Trump repositions 2 nuclear submarines after ‘highly provocative’...

August 1, 2025

Kavanaugh cites 3 presidents in explaining Supreme Court’s...

August 1, 2025

China’s growing nuclear arsenal aims to break US...

August 1, 2025

Trump ally Bukele’s party amends El Salvador constitution...

August 1, 2025

Trump takes jab at GOP senator, urging Republicans...

August 1, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • AUDUSD and AUDNZD: AUDUSD is making new high this morning

    September 16, 2024
  • Donald Trump’s Truth Social: Could he reap billions from the controversial platform?

    July 24, 2024
  • Trump’s ‘Make America Healthy Again’ commission to target autism, chronic diseases

    February 13, 2025
  • Barron Trump debuts at father’s Florida campaign rally to sustained applause

    July 11, 2024
  • ‘Colonies problem’: Delegate’s mic cut after outcry during House speaker vote

    January 3, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (5,602)
  • Investing (634)
  • Stock (867)

Latest Posts

  • Russia says US relations ‘on the brink of a breakup,’ won’t confirm Trump-Putin talk

    February 11, 2025
  • GAINTOMO AI™: Crypto Trading with Intelligent Automation

    November 19, 2024
  • Trump allies warn Biden risking ‘World War III’ by authorizing long-range missiles for Ukraine

    November 18, 2024

Recent Posts

  • US Army soldier charged over alleged hacking of Trump, Harris phone records

    January 2, 2025
  • Trump taps Matt Gaetz for attorney general

    November 13, 2024
  • Former Ozy Media head sentenced to nearly 10 years in prison

    December 17, 2024

Editor’s Pick

  • State, Treasury Departments reimposes ‘maximum pressure’ sanctions on Iran’s oil trade

    February 24, 2025
  • Reporters say they found Waltz, Gabbard, Hegseth private contact info online

    March 27, 2025
  • WH study warns 9 million Americans could lose health insurance in ‘major’ recession if Trump budget bill fails

    May 18, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock